Patents by Inventor Olivier Blondel

Olivier Blondel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALBUMIN FUSION PROTEINS
    Publication number: 20140179596
    Abstract: Provided herein are albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins and vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins and using these nucleic acids, vectors, and/or host cells also are provided. Further described are pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: August 13, 2013
    Publication date: June 26, 2014
    Applicant: Human Genome Sciences, Inc.
    Inventors: Craig A. Rosen, Steven M. Ruben, Olivier Blondel
  • Albumin fusion proteins comprising insulin polypeptides
    Patent number: 8211439
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: July 3, 2012
    Assignee: Human Genome Sciences, Inc.
    Inventors: Craig A. Rosen, Steven M. Ruben, Olivier Blondel
  • ACRP30-like polynucleotides, polypeptides, and antibodies
    Publication number: 20030224425
    Abstract: The present invention relates to novel human ACRP30-Like polypeptides and isolated nucleic acids containing the coding regions of the genes encoding such polypeptides. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human ACRP30-Like polypeptides. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human ACRP30-Like polypeptides.
    Type: Application
    Filed: April 11, 2003
    Publication date: December 4, 2003
    Inventors: Olivier Blondel, Steven M. Ruben
  • Splice variants for human 5-HT4 serotonin receptor and their applications, in particular for screening
    Patent number: 6506580
    Abstract: The invention concerns an isolated polypeptide constitutive of splice variants for human serotonin receptor whereof the amino acid sequence is selected among the sequence SEQ ID No. 2 of the 5-HT4(c) polypeptide variant or the sequence SEQ ID No. 4 of the 5-HT4(d) polypeptide variant, or any polypeptide fragment or biologically active derivative thereof. The invention also concerns the inverse agonist effect of ML 10375 on 5-HT4(c) and 5-HT4(d) receptors.
    Type: Grant
    Filed: September 19, 2000
    Date of Patent: January 14, 2003
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Rodolphe Fischmeister, Michel Langlois, Yamina Dahmoune, Monique Gastineau, Olivier Blondel, Johan Hoebeke